IGF1 and osteoporosis: Furthermore, the findings that both the variation in peak BMD and circulating levels of IGF-I are largely genetically determined provide evidence that the differences in Igf-I expression caused by gene polymorphism could, in part, contribute to peak BMD differences and, therefore, the risk of osteoporosis [5].